Phosphorylation of the tumor suppressor protein p53 by mitogen-activated protein kinases - PubMed (original) (raw)
. 1994 Mar 25;269(12):9253-60.
Affiliations
- PMID: 7510706
Free article
Phosphorylation of the tumor suppressor protein p53 by mitogen-activated protein kinases
D M Milne et al. J Biol Chem. 1994.
Free article
Abstract
The p53 tumor suppressor protein is tightly regulated in the cell and is phosphorylated at multiple sites by several different protein kinases. We have investigated the phosphorylation of p53 by mitogen-activated protein (MAP) kinase, a protein kinase that plays a central role in mediating many mitogenic and differentiation signals. Recombinant wild-type mouse p53 was phosphorylated in vitro by activated recombinant p42-MAP kinase but not by inactive MAP kinase or by the activating protein, MAP kinase kinase. Phosphorylation of p53 by MAP kinase occurred at two N-terminal sites, threonine residues 73 and 83. Tryptic phosphopeptides of recombinant p53 phosphorylated in vitro by MAP kinase comigrated on two-dimensional maps with p53 from SV3T3 cells labeled in vivo with [32P]orthophosphate, suggesting that MAP kinase targets a site in p53 that is phosphorylated in the cell. Following serum stimulation of quiescent C57MG cells, two p53 kinases, which were resolved by chromatography on Mono Q, were stimulated 15-20-fold within 5 min. Each of these kinase activities co-eluted with myelin basic protein kinase activity and could be inactivated following treatment with protein phosphatase 2A, a serine/threonine phosphatase, or leukocyte antigen receptor, a protein tyrosine phosphatase, suggesting that these activities were members of the MAP kinase family. The two kinase activities from the lysates targeted the same phosphorylation sites on p53 as the purified recombinant MAP kinase. These protein kinase activities were also stimulated following exposure of the cells to ultraviolet radiation, but with slightly delayed kinetics. Phorbol ester treatment of SV3T3 cells led to increased phosphorylation of the peptide containing the residues targeted by MAP kinase. The data suggest that p53 may be phosphorylated by MAP kinase physiologically and that this interaction may be involved in the cell's response to UV exposure, growth factor stimulation, or transformation by oncogenes.
Similar articles
- p53 is phosphorylated in vitro and in vivo by an ultraviolet radiation-induced protein kinase characteristic of the c-Jun kinase, JNK1.
Milne DM, Campbell LE, Campbell DG, Meek DW. Milne DM, et al. J Biol Chem. 1995 Mar 10;270(10):5511-8. doi: 10.1074/jbc.270.10.5511. J Biol Chem. 1995. PMID: 7890669 - Insulin and 12-O-tetradecanoylphorbol-13-acetate activation of two immunologically distinct myelin basic protein/microtubule-associated protein 2 (MBP/MAP2) kinases via de novo phosphorylation of threonine and tyrosine residues.
Tobe K, Kadowaki T, Tamemoto H, Ueki K, Hara K, Koshio O, Momomura K, Gotoh Y, Nishida E, Akanuma Y, et al. Tobe K, et al. J Biol Chem. 1991 Dec 25;266(36):24793-803. J Biol Chem. 1991. PMID: 1662217 - Identification of epidermal growth factor Thr-669 phosphorylation site peptide kinases as distinct MAP kinases and p34cdc2.
Sanghera JS, Hall FL, Warburton D, Campbell D, Pelech SL. Sanghera JS, et al. Biochim Biophys Acta. 1992 Jun 29;1135(3):335-42. doi: 10.1016/0167-4889(92)90240-c. Biochim Biophys Acta. 1992. PMID: 1320411 - p53 N-terminal phosphorylation: a defining layer of complex regulation.
Jenkins LM, Durell SR, Mazur SJ, Appella E. Jenkins LM, et al. Carcinogenesis. 2012 Aug;33(8):1441-9. doi: 10.1093/carcin/bgs145. Epub 2012 Apr 12. Carcinogenesis. 2012. PMID: 22505655 Free PMC article. Review.
Cited by
- Emerging role and therapeutic implications of p53 in intervertebral disc degeneration.
Wang Y, Hu S, Zhang W, Zhang B, Yang Z. Wang Y, et al. Cell Death Discov. 2023 Dec 1;9(1):433. doi: 10.1038/s41420-023-01730-5. Cell Death Discov. 2023. PMID: 38040675 Free PMC article. Review. - VRK1 functional insufficiency due to alterations in protein stability or kinase activity of human VRK1 pathogenic variants implicated in neuromotor syndromes.
Martín-Doncel E, Rojas AM, Cantarero L, Lazo PA. Martín-Doncel E, et al. Sci Rep. 2019 Sep 16;9(1):13381. doi: 10.1038/s41598-019-49821-7. Sci Rep. 2019. PMID: 31527692 Free PMC article. - Strategies for Overcoming Resistance in Tumours Harboring BRAF Mutations.
Obaid NM, Bedard K, Huang WY. Obaid NM, et al. Int J Mol Sci. 2017 Mar 8;18(3):585. doi: 10.3390/ijms18030585. Int J Mol Sci. 2017. PMID: 28282860 Free PMC article. Review. - Role of Bcl-xL/Beclin-1 in synergistic apoptotic effects of secretory TRAIL-armed adenovirus in combination with mitomycin C and hyperthermia on colon cancer cells.
Kim SY, Lee DH, Song X, Bartlett DL, Kwon YT, Lee YJ. Kim SY, et al. Apoptosis. 2014 Nov;19(11):1603-15. doi: 10.1007/s10495-014-1028-6. Apoptosis. 2014. PMID: 25156145 Free PMC article. - Prolyl isomerase Pin1 in cancer.
Lu Z, Hunter T. Lu Z, et al. Cell Res. 2014 Sep;24(9):1033-49. doi: 10.1038/cr.2014.109. Epub 2014 Aug 15. Cell Res. 2014. PMID: 25124924 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous